These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9827938)

  • 1. Primordial role of CD34+ 38- cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation.
    Hénon P; Sovalat H; Becker M; Arkam Y; Ojeda-Uribe M; Raidot JP; Husseini F; Wunder E; Bourderont D; Audhuy B
    Br J Haematol; 1998 Nov; 103(2):568-81. PubMed ID: 9827938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the CD34+ 38- cells in posttransplant hematopoietic recovery.
    Hénon P; Sovalat H; Bourderont D; Ojeda-Uribe M; Arkam Y; Wunder E; Raidot JP; Husseini F; Audhuy B
    Stem Cells; 1998; 16 Suppl 1():113-22. PubMed ID: 11012153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsets of CD34+ hematopoietic progenitors and platelet recovery after high dose chemotherapy and peripheral blood stem cell transplantation.
    Meldgaard Knudsen L; Jensen L; Jarlbaek L; Hansen PG; Hansen SW; Drivsholm L; Nikolaisen K; Gaarsdal E; Johnsen HE
    Haematologica; 1999 Jun; 84(6):517-24. PubMed ID: 10366795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of CD34+ cell subsets in autologous PBSC transplantation: the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment.
    Hénon PH; Sovalat H; Bourderont D
    J Biol Regul Homeost Agents; 2001; 15(1):62-7. PubMed ID: 11388746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of marrow reserve from dose-intensified chemotherapy results in impaired hematopoietic reconstitution after autologous transplantation: CD34(+), CD34(+)38(-), and week-6 CAFC assays predict poor engraftment.
    Robinson SN; Freedman AS; Neuberg DS; Nadler LM; Mauch PM
    Exp Hematol; 2000 Dec; 28(12):1325-33. PubMed ID: 11146154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve.
    Pratt G; Rawstron AC; English AE; Johnson RJ; Jack AS; Morgan GJ; Smith GM
    Br J Haematol; 2001 Sep; 114(4):937-43. PubMed ID: 11564089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of CD34+ cells, CD34+ subsets, colony forming cells and cobblestone area forming cells in cord blood and bone marrow allografts.
    Theilgaard-Mönch K; Raaschou-Jensen K; Heilmann C; Andersen H; Bock J; Russel CA; Vindeløv L; Jacobsen N; Dickmeiss E
    Eur J Haematol; 1999 Mar; 62(3):174-83. PubMed ID: 10089895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of CD34+/CD33- cells in platelet engraftment after intensive therapy for cancer patients given peripheral blood stem cell rescue.
    Millar BC; Millar JL; Shepherd V; Blackwell P; Porter H; Cunningham D; Judson I; Treleaven J; Powles RL; Catovsky D
    Bone Marrow Transplant; 1998 Sep; 22(5):469-75. PubMed ID: 9733270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+CD38-HLA-DR- correlate more closely than CD34+CD38- with engraftment post-PBSC transplantation.
    Drake M; Ranaghan EA; Alexander HD; Desai ZR; Morris TC
    Br J Haematol; 1999 Mar; 104(3):643-4. PubMed ID: 10086811
    [No Abstract]   [Full Text] [Related]  

  • 10. Early and long-term engraftment after autologous peripheral stem cell transplantation in acute myeloid leukemia patients.
    Specchia G; Pastore D; Mestice A; Liso A; Carluccio P; Leo M; Casanova M; Sibilla S; Giannoccaro M; Liso V
    Acta Haematol; 2006; 116(4):229-37. PubMed ID: 17119322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.
    Katayama Y; Mahmut N; Takimoto H; Maeda Y; Yano T; Kojima K; Azuma T; Hara M; Imajyo K; Takahashi S; Kai T; Ohno Y; Miyamoto T; Nagafuji K; Matsue K; Takenaka K; Teshima T; Shinagawa K; Ishimaru F; Omoto E; Harada M
    Bone Marrow Transplant; 1999 Apr; 23(7):659-65. PubMed ID: 10218841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD34+/CD90+ cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation.
    Sumikuma T; Shimazaki C; Inaba T; Ochiai N; Okano A; Hatsuse M; Ashihara E; Nakagawa M
    Br J Haematol; 2002 Apr; 117(1):238-44. PubMed ID: 11918561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD133+CD34+ and CD133+CD38+ blood progenitor cells as predictors of platelet engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
    Camacho Villa AY; Reyes Maldonado E; Montiel Cervantes LA; Vela Ojeda J
    Transfus Apher Sci; 2012 Jun; 46(3):239-44. PubMed ID: 22386660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of processing four and five times the patients' blood volume during peripheral blood stem cell collection and analysis of CD34+38--and CD34+49d+ subsets during apheresis.
    Bojko P; Scharifi M; Stössel K; Seeber S
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):19-28. PubMed ID: 11862468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD34+CD33- cells influence days to engraftment and transfusion requirements in autologous blood stem-cell recipients.
    Pecora AL; Preti RA; Gleim GW; Jennis A; Zahos K; Cantwell S; Doria L; Isaacs R; Gillio AP; Michelis MA; Brochstein JA
    J Clin Oncol; 1998 Jun; 16(6):2093-104. PubMed ID: 9626209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors predicting haematopoietic recovery in patients undergoing autologous transplantation: 11-year experience from a single centre.
    Bai L; Xia W; Wong K; Reid C; Ward C; Greenwood M
    Ann Hematol; 2014 Oct; 93(10):1655-64. PubMed ID: 24870941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous peripheral blood progenitor cell transplantation with <2 x 10(6) CD34(+)/kg: an analysis of variables concerning mobilisation and engraftment.
    Villalón L; Odriozola J; Laraña JG; Zamora C; Pérez de Oteyza J; Jodra MH; López J; Herrera P; Roldán E; Ramos ML; Ramos P; Navarro JL
    Hematol J; 2000; 1(6):374-81. PubMed ID: 11920217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous transplantation of blood stem cells mobilized with filgrastim alone in 93 patients with malignancies: the number of CD34+ cells reinfused is the only factor predicting both granulocyte and platelet recovery.
    Faucher C; Le Corroller AG; Chabannon C; Viens P; Stoppa AM; Bouabdallah R; Camerlo J; Vey N; Gravis G; Gastaut JA; Novakovitch G; Mannoni P; Bardou VJ; Moatti JP; Maraninchi D; Blaise D
    J Hematother; 1996 Dec; 5(6):663-70. PubMed ID: 9117255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viable CD34+/CD133+ blood progenitor cell dose as a predictor of haematopoietic engraftment in multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    Hicks C; Wong R; Manoharan A; Kwan YL
    Ann Hematol; 2007 Aug; 86(8):591-8. PubMed ID: 17492259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of preleukapheresis cell counts on collection results and correlation of progenitor-cell dose with engraftment after high-dose chemotherapy in patients with germ cell cancer.
    Schwella N; Beyer J; Schwaner I; Heuft HG; Rick O; Huhn D; Serke S; Siegert W
    J Clin Oncol; 1996 Apr; 14(4):1114-21. PubMed ID: 8648365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.